Carregant...
EpCAM an immunotherapeutic target for gastrointestinal malignancy: current experience and future challenges
Despite advances in surgery and adjuvant regimes, gastrointestinal malignancy remains a major cause of neoplastic mortality. Immunotherapy is an emerging and now successful treatment modality for numerous cancers that relies on the manipulation of the immune system and its effector functions to erad...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group
2007
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2360124/ https://ncbi.nlm.nih.gov/pubmed/17325709 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603505 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|